tradingkey.logo

Deals of the day-Mergers and acquisitions

ReutersFeb 11, 2025 2:43 PM

- The following bids, mergers, acquisitions and disposals were reported by 1430 GMT on Tuesday:

** Swiss pharmaceutical giant Novartis has agreed to acquire Anthos Therapeutics, a biopharma firm majority-owned by Blackstone's BX.N drug development unit, for up to $3.1 billion, to boost its cardiovascular business.

nL8N3P20AT

** Novonesis said that it had agreed to buy the stake of its partner, Swiss-Dutch chemical manufacturer DSM-Firmenich, in their joint enzymes venture for 1.5 billion euros ($1.55 billion).

nL8N3P20AB

** Canada's Toronto-Dominion Bank said it would sell 165.4 million shares in Charles Schwab for $79.25 per share.

nL4N3P20BH

** Singapore's Paragon REIT said it received a buyout offer from its major shareholder, Cuscaden Peak, and parties valuing the real estate firm at S$2.78 billion ($2.05 billion).

nL4N3P11XE

** Merck KGaA MRCG.DE, the German healthcare and technology group, said on Monday it is in advanced talks to acquire U.S. cancer and rare diseases drugmaker SpringWorks Therapeutics .

nL1N3P119V

** Afore Insurance Services has acquired Franklin, Tennessee-based Broussard and Associates, Inc, operating as Innovative Insurance Services.

nL6N3P10QF

** Emerson Electric said on Monday that its $265 per-share offer to acquire Aspen Technology was its "best and final" price.

nL4N3P11K6

** Fox Corp said on Monday it has purchased Red Seat Ventures, the digital media company whose clients include former Fox News stars Megyn Kelly and Tucker Carlson, in a bid to tap younger audiences and the growing podcast market.

nL4N3P119G

** Hub International Limited has acquired the assets of St. Louis, Missouri-based Yavitz Insurance Group.

nL6N3P10K3

** FactSet FDS.N said on Monday it has acquired trade management platform LiquidityBook in an all-cash deal valued at $246.5 million as the financial data services firm seeks to provide more consolidated solutions to its clients.

nL4N3P10VS

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI